Your browser doesn't support javascript.
loading
Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials.
Blauvelt, A; Reich, K; Papp, K A; Kimball, A B; Gooderham, M; Tyring, S K; Sinclair, R; Thaçi, D; Li, Q; Cichanowitz, N; Green, S; La Rosa, C.
  • Blauvelt A; Oregon Medical Research Center, 9495 SW Locust St, Suite G, Portland, OR, 97223, U.S.A.
  • Reich K; Dermatologikum Berlin, Berlin, Germany.
  • Papp KA; ScIderm Research Institute, Hamburg, Germany.
  • Kimball AB; K. Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada.
  • Gooderham M; Harvard Medical School, Boston, MA, U.S.A.
  • Tyring SK; SKiN Centre for Dermatology and Probity Medical Research, Peterborough, ON, Canada.
  • Sinclair R; Queens University, Kingston, ON, Canada.
  • Thaçi D; Department of Dermatology, University of Texas, Houston, TX, U.S.A.
  • Li Q; University of Melbourne, Melbourne, Vic., Australia.
  • Cichanowitz N; University of Lübeck, Lübeck, Germany.
  • Green S; Merck & Co., Inc., Kenilworth, NJ, U.S.A.
  • La Rosa C; Merck & Co., Inc., Kenilworth, NJ, U.S.A.
Br J Dermatol ; 179(3): 615-622, 2018 09.
Article en En | MEDLINE | ID: mdl-29742274
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Psoriasis / Inmunosupresores / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Psoriasis / Inmunosupresores / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Diagnostic_studies Idioma: En Año: 2018 Tipo del documento: Article